Marc Buyse is the Founder of One2Treat, a company focused on evaluating treatment effects comprehensively. Marc also holds multiple titles at IDDI and CluePoints, where Marc uses their expertise in biostatistics. With a background in engineering and a ScD in Biostatistics from Harvard T.H. Chan School of Public Health, Marc has made significant contributions to the field across various roles in academia and industry.
Sign up to view 0 direct reports
Get started
This person is not in any offices